Lead Optimization of Spiropyrazolopyridones: A New and Potent Class of Dengue Virus Inhibitors
- 4 February 2015
- journal article
- research article
- Published by American Chemical Society (ACS) in ACS Medicinal Chemistry Letters
- Vol. 6 (3) , 344-348
Abstract
Spiropyrazolopyridone 1 was identified, as a novel dengue virus (DENV) inhibitor, from a DENV serotype 2 (DENV-2) high-throughput phenotypic screen. As a general trend within this chemical class, chiral resolution of the racemate revealed that R enantiomer was significantly more potent than the S. Cell-based lead optimization of the spiropyrazolopyridones focusing on improving the physicochemical properties is described. As a result, an optimal compound 14a, with balanced in vitro potency and pharmacokinetic profile, achieved about 1.9 log viremia reduction at 3 × 50 mg/kg (bid) or 3 × 100 mg/kg (QD) oral doses in the dengue in vivo mouse efficacy model.Keywords
This publication has 21 references indexed in Scilit:
- DengueNew England Journal of Medicine, 2012
- Inhibition of Dengue Virus by Targeting Viral NS4B ProteinJournal of Virology, 2011
- A Translation Inhibitor That Suppresses Dengue VirusIn VitroandIn VivoAntimicrobial Agents and Chemotherapy, 2011
- Inhibition of Dengue Virus through Suppression of Host Pyrimidine BiosynthesisJournal of Virology, 2011
- Spirotetrahydro β-Carbolines (Spiroindolones): A New Class of Potent and Orally Efficacious Compounds for the Treatment of MalariaJournal of Medicinal Chemistry, 2010
- An adenosine nucleoside inhibitor of dengue virusProceedings of the National Academy of Sciences, 2009
- The Medicinal Chemistry of Dengue FeverJournal of Medicinal Chemistry, 2009
- Three-component condensation of 5-aminopyrazole derivatives with isatins and Meldrum’s acid. Synthesis of 1,7-dihydrospiro[pyrazolo[3,4-b]-pyridine-4,3′-indole]-2′,6(1′H,5H)-dionesRussian Chemical Bulletin, 2009
- A Dengue Fever Viremia Model in Mice Shows Reduction in Viral Replication and Suppression of the Inflammatory Response after Treatment with Antiviral DrugsThe Journal of Infectious Diseases, 2007
- Synthesis of 7,8‐dihydro‐6H‐pyrazolo[3,4‐b]quinolin‐5‐ones and related derivativesJournal of Heterocyclic Chemistry, 1991